February 29, 2024spanish

US Bioequivalence

Home / Sin categoría / US Bioequivalence

Cyndea succesfully finished in July the first US Bioequivalence study for one of the products developed by its R&D department. This is a big milestone in the road of manufacturing for our US customers.

Cyndea is nowadays developing up to 8 ANDAs. The Us market is a strategic territory where we at Cyndea want to focus our efforts.


Recent Posts

We're not around right now. But you can send us an email and we'll get back to you, asap.